title: [Infectious diseases].
abstract: The recommendations for the treatment of gonorrhea have been changed: ceftriaxone 500 mg IM plus azithromycin 1 g PO is recommended. Prophylaxis of recurrent cellulitis with penicillin 250 mg 2 x/d PO may be considered. E. coli ESBL does not require contact isolation anymore. Fecal transplantation seems so far to be the most effective treatment of recurrent C. dificile. Two new respiratory viruses, Middle East Coronavirus (MERS-CoV) and avian-origin Influenza A (H7N9) have been reported. Oral valganciclovir treatment reduces the risk of hearing loss in congenital CMV infection. An outbreak of mould infections of the central nervous system has been described in the United States following injection of contaminated steroids.
authors.affiliation: Sercive des Maladies Infectieuses Département de Médicine, CHUV, Lausanne. cathy.voide@chuv.ch
authors.forename: Cathy
authors.initials: C
authors.lastname: Voide
authors.affiliation: Unité d'Infectiologie Pédiatrique et Vaccinologie Département Médico-Chirurgical de Pédiatrie CHUV, Lausanne.
authors.forename: Sandra
authors.initials: S
authors.lastname: Asner
authors.affiliation: Sercive des Maladies Infectieuses Département de Médicine, CHUV, Lausanne.
authors.forename: Stefano
authors.initials: S
authors.lastname: Giulieri
authors.affiliation: Sercive des Maladies Infectieuses Département de Médicine, CHUV, Lausanne.
authors.forename: Matthias
authors.initials: M
authors.lastname: Cavassini
authors.affiliation: Sercive des Maladies Infectieuses Département de Médicine, CHUV, Lausanne.
authors.forename: Laurent
authors.initials: L
authors.lastname: Merz
authors.affiliation: Sercive des Maladies Infectieuses Département de Médicine, CHUV, Lausanne.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Tissot
authors.affiliation: Sercive des Maladies Infectieuses Département de Médicine, CHUV, Lausanne.
authors.forename: Christina
authors.initials: C
authors.lastname: Orasch
mesh_terms: D002681:China / Q000453:epidemiology; D021821:Communicable Diseases, Emerging / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D004340:Drug Contamination; D004352:Drug Resistance, Microbial; D006069:Gonorrhea / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D064766:Influenza A Virus, H7N9 Subtype; D007251:Influenza, Human / Q000453:epidemiology / Q000821:virology; D009181:Mycoses / Q000209:etiology; D014481:United States / Q000453:epidemiology
vernacular_title: Maladies infectieuses.